Every round on record, with the sources behind each and the investors on them.
A biotech company
draigtherapeutics.comU.K.BiotechFounded 2024
1 source
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The Series A amount is not separately stated. The $140 million (£107 million) figure is total investment raised over nine months, including the seed financing; SV Health Investors and ICG are identified as seed investors.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series A [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $140M (£107 million) financing total | 2025-06-18 | Access Biotechnology | No recent discussion |
1 source [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 source
The Series A amount is not separately stated. The $140 million (£107 million) figure is total investment raised over nine months, including the seed financing; SV Health Investors and ICG are identified as seed investors. | ||||
Draig Therapeutics is a clinical-stage biopharmaceutical company developing highly specific AMPA and GABAA receptor modulators to treat neuropsychiatric disorders.
Checked against 8 sources today
Also named as backers in company research: SV Health Investors, ICG, Deep Track Capital, Janus Henderson Investors, Marshall Wace, British Business Bank, Jefferson Life Sciences